Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies.

about

Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies.

Item

http://www.wikidata.org/entity/Q44209876

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Double allogeneic hematopoieti ...... sk hematological malignancies.

@en

Double allogeneic hematopoieti ...... sk hematological malignancies.

@nl

type

Item

label

Double allogeneic hematopoieti ...... sk hematological malignancies.

@en

Double allogeneic hematopoieti ...... sk hematological malignancies.

@nl

prefLabel

Double allogeneic hematopoieti ...... sk hematological malignancies.

@en

Double allogeneic hematopoieti ...... sk hematological malignancies.

@nl

P1476

Double allogeneic hematopoieti ...... isk hematological malignancies

@en

P2093

A Gratwohl

http://www.w3.org/2001/XMLSchema#string

A Tichelli

http://www.w3.org/2001/XMLSchema#string

C Arber

http://www.w3.org/2001/XMLSchema#string

D Heim

http://www.w3.org/2001/XMLSchema#string

G Stussi

http://www.w3.org/2001/XMLSchema#string

J Halter

http://www.w3.org/2001/XMLSchema#string

J Rischewski

http://www.w3.org/2001/XMLSchema#string

M Paulussen

http://www.w3.org/2001/XMLSchema#string

S Meyer-Monard

http://www.w3.org/2001/XMLSchema#string

P2860

FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia.

Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone (FIS-HAM) salvage therapy in highly resistant acute leukemias.

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.

Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemia.

Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.

High-dose chemotherapy using BEAM for tumor debulking without stem cell support followed by early allogeneic reduced intensity conditioning transplantation to induce a graft-versus-lymphoma effect in patients with high risk or refractory lymphoma.

Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation.

Double allogeneic peripheral blood stem cell transplantation in a 9-year-old patient with relapsed acute lymphoblastic leukemia: case report.

Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG.

Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT).

P2888

bmt.2009.123

P304

103-109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2009.123

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andreas Buser

Jakob R. Passweg

P577

2009-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26325746

http://www.w3.org/2001/XMLSchema#string

P698

19561651

http://www.w3.org/2001/XMLSchema#string